IMPACT OF VALUE BASED PRICING ON FUTURE OF PATIENT ACCESS SCHEMES IN THE UK

被引：0

作者：

Izmirlieva, M. ^{[1
]}

Walker, S. ^{[1
]}

Marinoni, G. ^{[1
]}

Ando, G. ^{[2
]}

机构：

[1] IHS, London, England

[2] IHS Global Insight, London, England

来源：

VALUE IN HEALTH | 2012年 / 15卷 / 07期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A313 / A313

页数：1

共 50 条

[1] VALUE BASED PRICING: WHAT IS THE FUTURE FOR PATIENT ACCESS SCHEMES?
Loveman, C. M.
Mallinson, M.
Areteou, T.
White, R.
VALUE IN HEALTH, 2011, 14 (03) : A30 - A30
[2] VALUE-BASED PRICING IN THE UK AND POTENTIAL PATIENT ACCESS HURDLES TO INNOVATIVE DRUGS
Papadopoulou, K.
Grosvenor, A.
VALUE IN HEALTH, 2013, 16 (07) : A492 - A492
[3] Design of Patient Access Schemes in the UK
Jarostawski, Szymon
Toumi, Mondher
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2011, 9 (04) : 209 - 215
[4] Value based pricing, research and development, and patient access schemes. Will the United Kingdom get it right or wrong?
Towse, Adrian
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (03) : 360 - 366
[5] Value-Based Pricing and Patient Access for Specialty Drugs
Robinson, James C.
Howell, Scott
Pearson, Steven D.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (21): : 2169 - 2170
[6] PATIENT ACCESS SCHEMES WITHIN THE UK: A RETROSPECTIVE ANALYSIS
Maguire, P. T.
Gibson, E.
VALUE IN HEALTH, 2015, 18 (07) : A538 - A539
[7] A REGRESSION ANALYSIS OF THE IMPACT OF PATIENT ACCESS SCHEMES
Choksi, P.
VALUE IN HEALTH, 2013, 16 (03) : A268 - A268
[8] WHAT IS THE IMPACT OF COMPARATIVE EFFECTIVENESS AND VALUE BASED PRICING ON A PRODUCT'S VALUE AND MARKET ACCESS?
Walker, R.
Ng-Haing, J.
Koruth, R.
Sparrowhawk, K.
VALUE IN HEALTH, 2011, 14 (03) : A22 - A22
[9] Value-based pricing of drugs in the UK
Webb, David J.
Walker, Andrew
LANCET, 2007, 369 (9571): : 1415 - 1416
[10] "PATIENT ACCESS SCHEMES"-THE USE OF RISK-SHARING IN THE UK
Carroll, S. M.
Wasiak, R.
VALUE IN HEALTH, 2009, 12 (07) : A286 - A287

← 1 2 3 4 5 →